BunyaVax logo — company profile

BunyaVax

Founded 2017 The Netherlands The Netherlands 3 employees Grant Total: $71.43K Biotechnology, Health Care

General Information

Company Name BunyaVax
Founded Year 2017
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with BunyaVax. To contact BunyaVax, visit bunyavax.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BunyaVax compare?

A PDF of BunyaVax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BunyaVax soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BunyaVax

**BunyaVax** is a biotechnology startup based in The Netherlands, founded in 2017. The company's core focus lies in the development of vaccines against infectious diseases and cancer, utilizing proprietary vaccine platform technology. This innovative approach enables the generation of potent vaccines that can encode almost any antigen of interest, offering applications in both the veterinary and human healthcare settings. The latest investment in BunyaVax amounted to €71.43K in the form of a grant, which was received on 01 June 2018. The investor behind this considerable influx was EASME - EU Executive Agency for SMEs. This latest investment serves as a testament to the potential perceived in BunyaVax and its pioneering vaccine platform technology, signaling confidence and financial backing from a reputable European entity.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jun 2018

BunyaVax Alternatives & Competitors

View All Alternatives
BunyaVax vs
Pacific Genetech
Pacific Genetech United States

NextGen Vaccine Technologies

Venture round
9 employees
Agriculture, Biotechnology
BunyaVax vs
Rocketvax AG
Rocketvax AG Switzerland

Implementing cutting-edge science in next-generation vaccine design that will improve people’s lives...

Grant
6 employees
Biotechnology, Health Care
BunyaVax vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Venture round
7 employees
Biotechnology, Health Care

FAQ About BunyaVax

BunyaVax exploits proprietary vaccine platform technology to develop safe and efficacious vaccines against infectious diseases and cancer. The unique ‘Plug and Play’ platforms are used to generate potent vaccines that can encode almost any antigen of interest. Applications are in the veterinary and...
BunyaVax was founded in 2017.
BunyaVax is headquartered in The Netherlands.
BunyaVax operates in Biotechnology and Health Care.
BunyaVax has approximately 3 employees.
BunyaVax has completed 1 funding round, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to BunyaVax include Pacific Genetech, Rocketvax AG, Memgen, Inc., CaroGen Corporation, ACM Biolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BunyaVax and Pacific Genetech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BunyaVax, https://bouncewatch.com/company/bunyavax, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes